Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

  • The following term was not found in PubMed: Matamanda.
1.

Polycythemia vera: diagnosis, clinical course, and current management

Büyükaşik Y, Alİ R, Ar C, Turgut M, Yavuz S, Saydam G.

Turk J Med Sci. 2018 Aug 16;48(4):698-710. doi: 10.3906/sag-1806-43.

PMID:
30114348
2.

Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single Institution Experience.

Öngören Ş, Salihoğlu A, Apaydın T, Sadri S, Eşkazan AE, Ar MC, Elverdi T, Başlar Z, Aydın Y, Soysal T.

Balkan Med J. 2018 Jul 3. doi: 10.4274/balkanmedj.2017.1215. [Epub ahead of print]

3.

Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.

Erbilgin Y, Eskazan AE, Hatirnaz Ng O, Salihoglu A, Elverdi T, Firtina S, Tasar O, Mercan S, Sisko S, Khodzhaev K, Ongoren S, Ar MC, Baslar Z, Soysal T, Sayitoglu M, Ozbek U.

Leuk Lymphoma. 2018 Jul 2:1-9. doi: 10.1080/10428194.2018.1473573. [Epub ahead of print]

PMID:
29965782
4.

Ultrasound-guided subcostal-posterior transversus abdominis plane block for pain control following laparoscopic sleeve gastrectomy.

Arı DE, Ar AY, Karip CS, Köksal C, Aydın MT, Gazi M, Akgün F.

Saudi Med J. 2017 Dec;38(12):1224-1229. doi: 10.15537/smj.2017.12.21133.

5.

Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience.

Öngören Ş, Eşkazan AE, Berk S, Elverdi T, Salihoğlu A, Ar MC, Başlar Z, Aydın Y, Tüzüner N, Soysal T.

Turk J Haematol. 2017 Dec 1;34(4):291-299. doi: 10.4274/tjh.2016.0443.

6.

Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.

Ongoren S, Eskazan AE, Suzan V, Savci S, Erdogan Ozunal I, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Erbilgin Y, Iseri SA, Ar MC, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Hematology. 2018 May;23(4):212-220. doi: 10.1080/10245332.2017.1385193. Epub 2017 Oct 9. Review.

PMID:
28990873
8.

Participation in Physical and Sportive Activities among Adult Turkish People with Hemophilia: A Single-Center Experience.

Lehmeier A, Ar MC, Sadri S, Yürüyen M, Başlar Z.

Turk J Haematol. 2018 Mar 1;35(1):81-82. doi: 10.4274/tjh.2017.0292. Epub 2017 Sep 18. No abstract available.

9.

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.

Eskazan AE, Sadri S, Keskin D, Ayer M, Kantarcioglu B, Demirel N, Aydin D, Aydinli F, Yokus O, Ozunal IE, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Ongoren S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):804-811. doi: 10.1016/j.clml.2017.07.255. Epub 2017 Aug 4.

PMID:
28847475
10.

Comment and response to: the significance of early warning in chronic myeloid leukemia.

Eskazan AE, Ar MC, Soysal T.

Expert Rev Hematol. 2018 Apr;11(4):267-268. doi: 10.1080/17474086.2017.1340719. Epub 2017 Jun 15. No abstract available.

PMID:
28598700
11.

[Analgesia Nociception Index for perioperative analgesia monitoring in spinal surgery].

Turan G, Ar AY, Kuplay YY, Demiroluk O, Gazi M, Akgun N, Celikoglu E.

Rev Bras Anestesiol. 2017 Jul - Aug;67(4):370-375. doi: 10.1016/j.bjan.2017.03.004. Epub 2017 Apr 12. Portuguese.

12.

Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors.

Yalnız FF, Akkoç N, Salihoğlu A, Ar MC, Öngören Ş, Eşkazan AE, Soysal T, Aydın Y.

Turk J Haematol. 2017 Aug 2;34(3):233-238. doi: 10.4274/tjh.2016.0397. Epub 2017 Mar 8.

13.

Turkish adult children as caregivers of parents with Alzheimer's disease: Perceptions and caregiving experiences.

Ar Y, Karanci AN.

Dementia (London). 2017 Jan 1:1471301217693400. doi: 10.1177/1471301217693400. [Epub ahead of print]

PMID:
28201932
14.

Short-term clinico-radiological outcome of chronic knee synovitis among haemophilia A patients post phosphorus-32 radiosynoviorthesis.

Ty P, Menon J, Ar N, Halanaik D, Kramadhari H.

J Orthop Surg (Hong Kong). 2017 Jan;25(1):2309499016684500. doi: 10.1177/2309499016684500.

PMID:
28193140
15.

Current status of medical science in Turkey : Why this special issue?

Sengölge G, Ar MC.

Wien Klin Wochenschr. 2016 Dec;128(Suppl 8):557-558. doi: 10.1007/s00508-016-1130-6. No abstract available.

PMID:
28004264
16.

Personalized prophylaxis in people with hemophilia A: challenges and achievements.

Ar MC, Baslar Z, Soysal T.

Expert Rev Hematol. 2016 Dec;9(12):1203-1208. Epub 2016 Nov 4. Review.

PMID:
27809624
17.

Analysis of thrombosis and bleeding complications in patients with polycythemia vera: a Turkish retrospective study.

Yesilova AM, Yavuzer S, Yavuzer H, Cengiz M, Toprak ID, Hanedar E, Ar MC, Baslar Z.

Int J Hematol. 2017 Jan;105(1):70-78. doi: 10.1007/s12185-016-2105-0. Epub 2016 Oct 3.

PMID:
27699575
18.

Critical appraisal of European LeukemiaNet (ELN) 2013 recommendations for the management of chronic myeloid leukemia: is it early for a warning?

Eskazan AE, Ar MC, Soysal T.

Expert Rev Hematol. 2016 Oct;9(10):919-21. doi: 10.1080/17474086.2016.1231572. Epub 2016 Sep 8. No abstract available.

PMID:
27606433
19.

Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha.

Salihoglu A, Elverdi T, Eskazan AE, Eyice D, Bavunoglu I, Ar MC, Ongoren S, Guzel E, Baslar Z, Tunckale A, Tuzuner N, Soysal T.

Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):272-7. doi: 10.1007/s12288-015-0600-8. Epub 2015 Sep 21.

20.

Comparison of I-gel with Classic Laryngeal Mask Airway Regarding the Ease of Use and Clinical Performance.

Arı DE, Ar AY, Karip CŞ, Siyahkoç İ, Arslan AH, Akgün FN.

Turk J Anaesthesiol Reanim. 2015 Oct;43(5):299-303. doi: 10.5152/TJAR.2015.71542. Epub 2015 Aug 21.

21.

Treatment of patients with immune thrombocytopenia admitted to the emergency room.

Bavunoğlu I, Eşkazan AE, Ar MC, Cengiz M, Yavuzer S, Salihoğlu A, Öngören Ş, Tunçkale A, Soysal T.

Int J Hematol. 2016 Aug;104(2):216-22. doi: 10.1007/s12185-016-2003-5. Epub 2016 Apr 29.

PMID:
27129318
22.

Transmucosal gas-loss rates in middle ears initially filled with O2 or CO2.

Kania RE, Vérillaud B, Ars B, Tran Ba Huy P, Herman P, Ar A.

Hear Res. 2016 Oct;340:107-112. doi: 10.1016/j.heares.2016.04.003. Epub 2016 Apr 19.

PMID:
27106659
23.

Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia.

Tanrikulu Simsek E, Eskazan AE, Cengiz M, Ar MC, Ekizoglu S, Salihoglu A, Gulturk E, Elverdi T, Ongoren Aydin S, Senem Demiroz A, Buyru AN, Baslar Z, Ozbek U, Ferhanoglu B, Aydin Y, Tuzuner N, Soysal T.

J Clin Pathol. 2016 Sep;69(9):810-6. doi: 10.1136/jclinpath-2015-203320. Epub 2016 Jan 25.

PMID:
26811428
24.

Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey.

Sen E, Guclu SZ, Kibar I, Ocal U, Yilmaz V, Celik O, Cimen F, Topcu F, Orhun M, Tereci H, Konya A, Ar I, Saryal S.

Int J Chron Obstruct Pulmon Dis. 2015 Dec 10;10:2657-63. doi: 10.2147/COPD.S85324. eCollection 2015.

25.

Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study.

Gunen H, Yilmaz M, Aktas O, Ergun P, Ortakoylu MG, Demir A, Cetinkaya P, Gurgun A, Otlu M, Cilli A, Yilmaz U, Kokturk N, Candemir I, Yakar HI, Ar I, Konya A.

Int J Chron Obstruct Pulmon Dis. 2015 Nov 13;10:2485-94. doi: 10.2147/COPD.S87464. eCollection 2015.

26.

Correction: Whole Grain Intakes in the Diets Of Malaysian Children and Adolescents - Findings from the MyBreakfast Study.

Ak N, Koo HC, Jm HJ, Mt MN, Tan SY, Appukutty M, Ar N, Thielecke F, Hopkins S, Ong MK, Ning C, Tee ES.

PLoS One. 2015 Nov 6;10(11):e0142763. doi: 10.1371/journal.pone.0142763. eCollection 2015. No abstract available.

27.

Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide.

Salihoglu A, Ar MC, Soysal T.

Expert Rev Hematol. 2015 Dec;8(6):765-83. doi: 10.1586/17474086.2015.1091301. Epub 2015 Sep 28. Review.

PMID:
26413907
28.

Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis.

Öztürk E, Özbalak M, Berk S, Erdoğan I, Avşar E, Dolgun A, Çetiner M, Mandel NM, Yalnız FF, Elverdi T, Salihoğlu A, Eşkazan AE, Ar MC, Öngören Ş, Başlar Z, Aydın Y, Soysal T, Ferhanoğlu B.

Leuk Lymphoma. 2016 May;57(5):1211-4. doi: 10.3109/10428194.2015.1079319. Epub 2015 Oct 12. No abstract available.

PMID:
26294270
29.

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.

Demirel A, Tabak F, Ar MC, Mete B, Öngören Ş, Yemişen M, Özaras R, Eşkazan E, Başlar Z, Mert A, Soysal T, Ferhanoğlu B, Aydın Y, Öztürk R.

Turk J Haematol. 2015 Sep;32(3):243-50.

30.

Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?

Çetin G, Çıkrıkçıoğlu MA, Özkan T, Karatoprak C, Ar MC, Eşkazan AE, Ayer M, Cerit A, Gözübenli K, Uysal BB, Erdem S, Ergül N, Tatar G, Çermik TF.

Turk J Haematol. 2015 Sep;32(3):213-9. doi: 10.4274/tjh.2013.0336.

31.

The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients.

Yemişen M, Balkan İİ, Salihoğlu A, Eşkazan AE, Mete B, Ar MC, Öngören Ş, Başlar Z, Özaras R, Saltoğlu N, Mert A, Ferhanoğlu B, Öztürk R, Tabak F, Soysal T.

Turk J Haematol. 2016 Sep 5;33(3):216-22. doi: 10.4274/tjh.2014.0378. Epub 2015 May 4.

32.

Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy.

Eskazan AE, Hatemi İ, Öngören Aydın S, Ar MC, Soysal T.

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:233. doi: 10.5152/tjg.2014.5281. No abstract available.

33.

Recurrent Monosomies Confirmed by Interphase FISH in Three Chronic Myeloid Leukemia Cases.

Tarkan Argüden Y, Kuru D, Çırakoğlu A, Yılmaz Ş, Öngören Aydın Ş, Ar CM, Deviren A, Soysal T, Hacıhanefioğlu S.

Turk J Haematol. 2015 Mar 5;32(1):82-4. doi: 10.4274/tjh.2014.0374. No abstract available.

34.

Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey--GALATA study.

Ayvaz G, Keskin L, Akin F, Dokmetas HS, Tasan E, Ar IB, Uren E; GALATA Study Group.

Curr Med Res Opin. 2015 Apr;31(4):623-32. doi: 10.1185/03007995.2015.1019609. Epub 2015 Mar 16.

PMID:
25697921
35.

Value of preoperative sonographic vascular evaluation of haemodialysis access in upperlimb.

K C A, Srinath MG, Desai SC, Kumar A A, Ar C, Gowda A G G.

J Clin Diagn Res. 2014 Dec;8(12):RC06-10. doi: 10.7860/JCDR/2014/8944.5238. Epub 2014 Dec 5.

36.

[Activity Polish Physicians of Transcarpathian].

Ar P.

Wiad Lek. 2015;68(3 pt 2):419-420. Polish.

PMID:
28501847
37.

Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options.

Çetin G, Eşkazan AE, Ar MC, Aydın ŞÖ, Ferhanoğlu B, Soysal T, Başlar Z, Aydın Y.

Turk J Haematol. 2014 Dec 5;31(4):374-80. doi: 10.4274/tjh.2013.0004.

38.

Patients treated with therapeutic plasma exchange: a single center experience.

Sengul Samanci N, Ayer M, Gursu M, Ar MC, Yel K, Ergen A, Dogan EE, Karadag S, Cebeci E, Toptas M, Kazancioglu R, Ozturk S.

Transfus Apher Sci. 2014 Dec;51(3):83-9. doi: 10.1016/j.transci.2014.10.006. Epub 2014 Oct 8.

PMID:
25457747
39.

Generics in chronic myeloid leukemia: current arguments for and against and the established evidence.

Soysal T, Eskazan AE, Ar MC.

Expert Rev Hematol. 2014 Dec;7(6):697-9. doi: 10.1586/17474086.2014.966679. Epub 2014 Oct 8.

PMID:
25292262
40.

The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?

Eskazan AE, Ar MC, Soysal T.

Leuk Lymphoma. 2015 Apr;56(4):1182-3. doi: 10.3109/10428194.2014.947609. Epub 2014 Aug 20. No abstract available.

PMID:
25093378
41.

Methods for individualising factor VIII dosing in prophylaxis.

Ar MC, Vaide I, Berntorp E, Björkman S.

Eur J Haematol Suppl. 2014 Aug;76:16-20. doi: 10.1111/ejh.12370. Review.

PMID:
24957103
42.

Efficacy and safety of valsartan/amlodipine single-pill combination in patients with essential hypertension (PEAK LOW).

Kızılırmak P, Ar I, Ilerigelen B.

Turk Kardiyol Dern Ars. 2014 Jun;42(4):339-48. doi: 10.5543/tkda.2014.04206.

43.

A computerized recognition system for the home-based physiotherapy exercises using an RGBD camera.

Ar I, Akgul YS.

IEEE Trans Neural Syst Rehabil Eng. 2014 Nov;22(6):1160-71. doi: 10.1109/TNSRE.2014.2326254. Epub 2014 May 21.

PMID:
24860037
44.

Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion.

Eskazan AE, Eyice D, Kurt EA, Elverdi T, Yalniz FF, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Ferhanoglu B, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Leuk Res. 2014 Jul;38(7):781-7. doi: 10.1016/j.leukres.2014.04.004. Epub 2014 Apr 18.

PMID:
24832371
45.

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate.

Eskazan AE, Ayer M, Kantarcioglu B, Arica D, Demirel N, Aydin D, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Br J Haematol. 2014 Oct;167(1):139-41. doi: 10.1111/bjh.12937. Epub 2014 May 10. No abstract available.

PMID:
24815307
46.

The impact of obesity and insulin resistance on iron and red blood cell parameters: a single center, cross-sectional study.

Altunoğlu E, Müderrisoğlu C, Erdenen F, Ulgen E, Ar MC.

Turk J Haematol. 2014 Mar;31(1):61-7. doi: 10.4274/Tjh.2012.0187. Epub 2014 Mar 5.

47.

A Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A Patients.

Fidancı ID, Zülfikar B, Kavaklı K, Ar MC, Kılınç Y, Başlar Z, Cağlayan SH.

Turk J Haematol. 2014 Mar;31(1):17-24. doi: 10.4274/Tjh.2012.0197. Epub 2014 Mar 5.

48.

The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia.

Eskazan AE, Elverdi T, Yalniz FF, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.

Leuk Lymphoma. 2014 Dec;55(12):2935-7. doi: 10.3109/10428194.2014.905774. Epub 2014 May 6. No abstract available.

PMID:
24650055
49.

Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients.

Sahin F, Saydam G, Cömert M, Uz B, Yavuz AS, Turan E, Yönal I, Atay H, Keltikli E, Turgut M, Pehlivan M, Akay MO, Gürkan E, Paydaş S, Kahraman S, Demirkan F, Kırkızlar O, Akpınar S, Pamuk GE, Demir M, Ozbaş HM, Sönmez M, Gültürk M, Salihoğlu A, Eşkazan AE, Ar C, Haydaroğlu Şahin H, Ongören S, Başlar Z, Aydın Y, Yenere MN, Tüzüner N, Ferhanoğlu B, Haznedaroglu IC, Ilhan O, Soysal T.

Turk J Haematol. 2013 Dec;30(4):351-8. doi: 10.4274/tjh.2013.0151. Epub 2013 Dec 5.

50.

Portal hypertension and myeloproliferative neoplasms: a relationship revealed.

Toros AB, Gokcay S, Cetin G, Ar MC, Karagoz Y, Kesici B.

ISRN Hematol. 2013 Sep 16;2013:673781. doi: 10.1155/2013/673781. eCollection 2013.

Supplemental Content

Support Center